Source: HTC.
  • Fantasy 360 (VRAR) has signed a long-term VR development agreement with HTC Corporation
  • The company will assist HTC with developing its VIVE VR headset and further VR initiatives
  • It believes that HTC’s resources will take its technological expertise to new heights
  • HTC creates products, solutions and platforms in mobile and immersive technologies
  • Fantasy 360 Technologies is building the industry’s premier location-based metaverse platform
  • Fantasy 360 (VRAR) is down by 2.86 per cent trading at $0.17 per share

Fantasy 360 (VRAR) has signed a long-term VR development agreement with HTC Corporation.

The company will assist HTC with developing its VIVE VR headset and further VR initiatives.

It believes HTC’s platforms will allow it to leverage its knowledge in VR technology to create next-generation hyper-immersive metaverse experiences.

“We are very excited to work with HTC and VIVE, including access to their senior technical team, to create even more engaging and hyper-immersive user experiences,” said Tim Bieber, CEO of Fantasy 360.

“I believe the development initiatives will unlock an exciting and deeper level of innovation to further propel Fantasy 360’s products and technologies in such an exciting and evolving industry,” added Alvin Graylin, President of HTC China.

HTC creates products, solutions and platforms in mobile and immersive technologies.

Fantasy 360 Technologies is building the industry’s premier location-based metaverse platform.

Fantasy 360 (VRAR) is down by 2.86 per cent trading at $0.17 per share as of 11:09 am EST.

More From The Market Online

Liberty Defense expands its international customer base

Liberty Defense Holdings (TSXV:SCAN), a provider of artificial intelligence technologies, expands its international customer base.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.